Common use of Purchase Warrant Clause in Contracts

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _______ (“Holder”), as registered owner of this Purchase Warrant, to Sigma Labs, Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29, 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2, 2025 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ shares of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _______ Xxxxxx Xxxxx Securities, Inc. (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsSmart for Life, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29, 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2December 8, 2025 2027 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ 8,000 shares of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 0.35 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _______ EX Xxxxxx LLC (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsKairos Pharma, Inc.Ltd., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29, 2020 (beginning the “Commencement Effective Date”), and at or before 5:00 p.m., Eastern time, April 2September 16, 2025 2029 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ 54,250 shares (the “Shares”) of common stock of the Company, par value $0.001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 4.80 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_______ _] (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsNeuralstem, Inc., a Nevada corporation Inc. (the “Company”), Holder is entitled, at any time or from time to time from September 2913, 2020 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2September 13, 2025 2017 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [_______ ] shares of common stock Common Stock of the Company, par value $0.001 0.01 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 1.25 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _______ (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsCeres, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29March 4, 2020 (the 2015(the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2March 4, 2025 2019 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ 22,000 shares of common stock of the Company, par value $0.001 0.01 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 1.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _______ Xxxxxx Xxxxx Securities, Inc. (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsSmart for Life, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29, 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2December 8, 2025 2027 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ 114,286 shares of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 0.35 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _______ Platinum Arc LLC (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsHealthcare Triangle, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29April 11, 2020 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2October 12, 2025 2026 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ 261,000 shares of common stock of the Company, par value $0.001 0.00001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 4.40 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean October 12, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-259180) of the Company was declared effective by the Securities and Exchange Commission (“Registration Statement”).

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _______ Xxxxxx X. Xxxxxx, Xx. (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsSmart for Life, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29, 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2December 8, 2025 2027 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ 88,000 shares of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 0.35 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _______ Xxxxx Xxxxxxx (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsSmart for Life, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29, 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2December 8, 2025 2027 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ 18,286 shares of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 0.35 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_______ ___________] (“Holder”), as registered owner of this Purchase Warrant, to Sigma Labs, Superconductor Technologies Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29November 26, 2020 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2November 25, 2025 2016 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to _______ 100,000 shares of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 0.375 per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid for value received by or on behalf of _______ Titan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), [ ] (“Holder”), as registered owner of this Purchase Warrant, to Sigma Labs, Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from September 2920, 2020 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2September 20, 2025 2023 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [_______ ] shares of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 0.28 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_______ ] (“Holder”), as registered owner of this Purchase Warrant, to Sigma LabsSunCar Technology Group, Inc., a Nevada Cayman Island corporation (the “Company”), Holder is entitled, at any time or from time to time from September 29, 2020 [___] (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, April 2October 25, 2025 2028 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [_______ ] Class A ordinary shares of common stock of the Company, par value $0.001 per share Company (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.64 10.225 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.